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Marek’s disease virus (MDV) is a highly contagious oncogenic alphaherpesvirus that causes disease that is
both a cancer model and a continuing threat to the world’s poultry industry. This comprehensive gene
expression study analyzes the host response to infection in both resistant and susceptible lines of chickens and
inherent expression differences between the two lines following the infection of the host. A novel pathogenicity
mechanism, involving the downregulation of genes containing HIC1 transcription factor binding sites as early
as 4 days postinfection, was suggested from this analysis. HIC1 drives antitumor mechanisms, suggesting that
MDV infection switches off genes involved in antitumor regulation several days before the expression of the
MDV oncogene meq. The comparison of the gene expression data to previous QTL data identified several genes
as candidates for involvement in resistance to MD. One of these genes, IRG1, was confirmed by single nucleotide
polymorphism analysis to be involved in susceptibility. Its precise mechanism remains to be elucidated, although
the analysis of gene expression data suggests it has a role in apoptosis. Understanding which genes are involved in
susceptibility/resistance to MD and defining the pathological mechanisms of the disease gives us a much greater
ability to try to reduce the incidence of this virus, which is costly to the poultry industry in terms of both animal
welfare and economics.
Marek’s disease (MD) is a major disease affecting poultry
health and welfare, with estimated annual global losses of $2
billion (36). MD virus (MDV) is a highly contagious, cell-
associated, oncogenic alphaherpesvirus with biological
properties more similar to those of gammaherpesviruses, as
it is associated with T-cell lymphomas (43). MD continues to
be a serious threat to the health and welfare of poultry,
because although it has been controlled by vaccination for
more than 40 years, there is growing evidence that the in-
tensive use of vaccines is driving the virus to increasing
virulence (50), and new, more virulent strains of the virus
continue to emerge (12, 16). Infection with virulent strains
of serotype 1 MDV causes an early cytolytic infection (3 to
7 days postinfection [dpi]), primarily in B lymphocytes with
temporary, often profound, immunosuppression (7) and T-
cell activation. Once activated, T lymphocytes themselves
become susceptible to infection, which can be lytic, but after
about 7 dpi the virus enters latency (45). In susceptible
genotypes, a further cytolytic phase may occur about 2
weeks after infection, resulting in a permanent immunosup-
pression (8). The proliferative/transformation phase leading
to lymphoma formation starts around 21 to 28 dpi, although
T cells are likely to become transformed much earlier during
infection. The infection usually occurs by the respiratory
route, and the virus is spread through dander, the feather-
follicle epithelium being the only source of enveloped and
infectious cell-free MDV and therefore the site of virus
shedding.
As the current vaccination practices are thought to be
driving the virus to increasing virulence, an alternative
means to control MD would be through the selection and
breeding of birds with enhanced genetic resistance to MD.
Differences in genetic resistance to MD were first reported
nearly 80 years ago (2). Genes encoded in the major histo-
compatibility complex (MHC) locus have long been known
to contribute to MD resistance (24, 26) with a rough hier-
archy of resistance between haplotypes, with B21 being the
most resistant and B19 generally the most susceptible (24).
Despite this, other genes also have a strong influence on
MD resistance. This has been determined predominantly in
studies of the MHC-congenic lines 61 (resistant) and 72
(susceptible), which were developed in East Lansing, MI,
which differ in their resistance to a large number of MDV
isolates (38). Several potential MD resistance quantitative
trait loci (QTL) have been identified from crosses between
these lines and others (48, 52, 33, 11, 19), but relatively few
actual genes have been associated with the disease. Those
which have been identified include growth hormone (GH1)
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(27, 30), small inducible cytokine subfamily C member 1
(SCYC1) (29), and stem cell antigen 2 (SCA2) (31).
The availability of the chicken genome sequence (21) and
commercially available whole-genome microarrays has revolu-
tionized our ability to test candidate genes for disease resis-
tance. In recent years, a small number of microarray experi-
ments have been carried out to determine gene expression
changes occurring during the host response to MDV infection
and to identify genes involved in disease resistance (29, 40, 41).
However, these have been on a much smaller scale and there-
fore are more limited in their findings.
In this study, we have carried out a comprehensive gene
expression study using Affymetrix chicken whole-genome ar-
rays analyzing the host response to infection in both resistant
(61) and susceptible (72) lines and inherent expression differ-
ences between the two lines. Our assumption is that genes
controlling disease resistance will be involved during the initial
stages of infection, i.e., during the induced innate response to
infection, and we thus have concentrated on responses at 2, 3,
and 4 dpi.
The comparison of our gene expression data with QTL pre-
viously associated with MDV traits allowed us to identify can-
didate genes for resistance to MD, which then were fine
mapped using single nucleotide polymorphisms (SNPs) to de-
termine potential causative mutations for MD resistance/sus-
ceptibility. To our knowledge, this is the first time a large-scale
study has been carried out to assess the host innate response to
infection, identify SNPs in candidate genes, and validate those
disease resistance/susceptibility genes.
MATERIALS AND METHODS
Ethics statement. All animal work was conducted according to United King-
dom Home Office guidelines.
Experimental animals and design. Chicks were obtained from specified-
pathogen-free (SPF) parent flocks of the White Leghorn inbred lines 61 (MD
resistant) and 72 (MD susceptible), maintained at the Institute for Animal
Health, Compton, United Kingdom. As SPF chickens, the breeder hens were not
vaccinated and were shown to be free of MDV, avian leukosis virus, infectious
bursal disease virus, chicken infectious anemia virus, and other poultry patho-
gens, so the chicks used in these experiments were assumed to be free of
maternal antibodies against MDV.
At 2 weeks of age, chicks were selected at random and placed in infected or
control groups. Infected birds of both lines were housed in separate cages in the
same filtered-air positive-pressure isolation room and injected with 1,000 PFU
MDV strain RB1B in chicken kidney cell (CKC) suspension (0.2 ml) by the
intraperitoneal route. Similarly, controls were kept together in a separate isola-
tion room and injected with the same number of uninfected CKC (0.2 ml) by the
intraperitoneal route. Spleen and thymus samples from nine birds from each
group were collected at 2, 3 and 4 dpi.
RNA preparation. Tissue samples were stabilized in RNAlater (Ambion, War-
rington, United Kingdom) and disrupted using a bead mill (Retsch, Haan,
Germany) at 20 Hz for 4 min. Total RNA was prepared using the RNeasy minikit
(Qiagen, Crawley, United Kingdom) extraction according the manufacturer’s
protocol (Qiagen, Crawley, United Kingdom) to clean up the RNA further.
Concentrations of the RNA samples were calculated by measuring the optical
density at 260 nm (OD260) and OD280 on a spectrophotometer (NanoDrop;
Thermo Scientific). The quality of the RNA was checked on a bioanalyzer
(Agilent Technologies, South Queensferry, United Kingdom).
Microarray hybridization. Biotinylated fragmented cRNA was hybridized to
the Affymetrix chicken genome array. As well as genome-wide coverage of the
chicken, this array also contains 689 probe sets for detecting 684 transcripts
from 17 avian viruses (http://www.affymetrix.com/support/technical/datasheets
/chicken_datasheet.pdf). For each experimental group, three biological repli-
cates, consisting of three pools of three individual samples, were hybridized.
Thus, 72 arrays were used in total. Hybridization was performed at 45°C for 16 h
in a hybridization oven with constant rotation (60 rpm). The microarrays then
were automatically washed and stained with streptavidin-phycoerythrin conju-
gate (SAPE; Invitrogen, Paisley, United Kingdom) in a Genechip Fluidics station
(Affymetrix, Santa Clara, CA). Fluorescence intensities were scanned with a
GeneArray scanner 3000 (Affymetrix, Santa Clara, CA). The scanned images
were inspected and analyzed using established quality-control measures.
Statistical analysis of gene expression data. Gene expression data generated
from the GeneChip operating software (GCOS) was normalized using the
PLIER (probe logarithmic intensity error) method (1) within the Affymetrix
Expression Console software package. The normalized data then were analyzed
using the limma and FARMS (46) packages within R in Bioconductor. Probes
with a false discovery rate (FDR) of 0.05 and a fold change of 1.5 were
deemed significant.
Functional analysis of differentially expressed gene sets. The BioMart data-
mining tool within the Ensembl database (release 62) (http://www.ensembl.org
/biomart/index.html) was used to identify genes lying in areas of the genome
known to be associated with QTL for resistance to MD (as defined in Table S1
in the supplemental material). This information then was analyzed in conjunc-
tion with the gene expression data to identify potential candidate genes for
disease resistance.
To determine which biological pathways are involved in the responses to viral
infection, Pathway Express within the Onto-Tools suite (http://vortex.cs.wayne
.edu/projects.htm) was used. Genes differentially expressed during the host re-
sponse (P 0.05) were analyzed against a reference background consisting of all
genes found to be expressed on the arrays. Annotation was based upon the
equivalent human genes.
Genes were clustered by similar expression patterns and analyzed for enriched
gene ontology (GO) terms and transcription factor binding sites using the Ex-
pander (v4.1.1) software package (http://acgt.cs.tau.ac.il/expander/expander
.html). Normalized expression data from control samples were compared to data
from infected samples to examine the host response, while expression data from
each of the susceptible and resistant lines also were compared. The enrichment
of particular GO terms or transcription factor (TF) binding sites within clusters
was done by using the TANGO and PRIMA algorithms, respectively, within the
Expander package.
The use of the ingenuity pathway analysis (IPA) program (Ingenuity Systems)
revealed which canonical pathways are being switched on by MDV infection in
the host (with Benjamini-Hochberg multiple testing correction) and allowed us
to analyze the gene interaction networks involved in both the host response and
the interaction with IRG1.
Genes having an expression profile similar to that of IRG1 were identified with
Biolayout Express 3D (update 7) (47). Total raw expression data from the host
response comparison were analyzed with a cutoff of P  0.9. EasyGO (http:
//bioinformatics.cau.edu.cn/easygo/) then was used to examine enriched gene
ontology terms within the genes which grouped together with IRG1.
Quantitative real-time PCR and reverse transcription-PCR (RT-PCR). Prim-
ers and probe were designed using the Primer Express software program (Ap-
plied Biosystems, Warrington, United Kingdom) (see Table S2 in the supple-
mental material). All probes were labeled with the fluorescent reporter dye
5-carboxyfluorescein (FAM) at the 5 end and the quencher N, N, N, N-tetram-
ethyl-6-carboxyrhodamine (TAMRA) at the 3 end.
Real-time quantitative RT-PCR (qRT-PCR) was performed using the reverse trans-
criptase qPCR Master Mix RT-PCR kit (Applied Biosystems). The amplification and
detection of specific products were performed using the ABI 7500 FAST sequence
detection system (Applied Biosystems) with the following cycle profile: 1 cycle of 50°C
for 2 min, 60°C for 30 min, and 95°C for 5 min, and 40 cycles of 94°C for 20 s and 59°C
for 1 min. Normalization was carried out against 28S rRNA, which was used as a
housekeeping gene. Fold changes in RNA levels were calculated from mean
40-Ct values by the formula 2(40-Ct in infected line  40-Ct in control line) or
2(40-Ct in control line 61  40-Ct in control line 72).
Sequencing of candidate gene promoters. Primers were designed around the
proximal promoter region (700 bp preceding the ATG start codon) of each
candidate gene (see Table S2 in the supplemental material). Promoter regions
were amplified from 20 ng genomic DNA with 10 pmol of each primer in a final
volume of 20 l using FastStart Taq polymerase (Roche, Welwyn Garden City,
United Kingdom). This was used with the supplied reaction buffer containing 200
M each deoxynucleoside triphosphate (dNTP) and 1 GC-RICH solution
(Roche, Welwyn Garden City, United Kingdom). Amplification conditions were
10 min at 95°C; 30 cycles of 30 s at 95°C, 30 s at 55°C or 60°C, and 1 min at 72°C;
and 5 min at 72°C. Prior to sequencing, 10 l of each PCR was treated with 8 U
of exonuclease I (New England BioLabs, Hitchin, United Kingdom) and 0.8 U of
shrimp alkaline phosphatase (USB, Staufen, Germany) for 15 min at 37°C and 15
min at 80°C to remove primers and dNTPs, respectively. The cleaned-up PCR
products were sequenced in both directions with the same primers used for
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amplification using ABI BigDye Terminator chemistry, version 3.1, and an ABI
3730 sequencer (Applied Biosystems, Foster City, CA).
Backcross population. A first-generation backcross was generated by crossing
birds of line 61  line 72 F1 generation (6 males) with susceptible line 72 birds
(20 females). Members of the resulting backcross progeny were infected at 3
weeks of age with the moderate, classical strain of MDV, HPRS16. Blood
samples were taken at 4, 11, and 39 dpi, and viral loads were determined by
quantitative PCR. On postmortem, tumor development was recorded as N (neu-
ral), V (visceral), NV (both), or negative (). Death and viral load assessed by
PCR were used as QTL traits (the latter shows a high correlation with subse-
quent tumor development). From the experiment of 85 birds plus parental birds,
47 animals were chosen for mapping on the basis of survival (strongly correlated
to viral load PCR) or death with the highest viral load titers.
SNP genotyping. Thirteen SNPs from the promoter regions of the MD resis-
tance candidate genes were screened in the parent lines 61 and 72 to identify
which were fully informative for the mapping study. These SNPs were previously
identified from sequencing the promoter regions within a single line 61 bird and
a single line 72 bird for the gene of interest. SNPs were selected on the basis of
their homozygosity in each line and the divergence of the homozygous allele in
the parent lines. Thus, only six SNPs that were fully fixed and divergent between
the parent lines were selected for a fully informative analysis. Informative SNPs
(see Table S2 in the supplemental material) were PCR amplified using 50 to 100
ng genomic DNA, 200 M each dNTP, and 400 pmol of each primer, in a total
reaction volume of 12.5 l. Genotypes were generated in the MDV backcross
mapping panel using a fragment analysis assay on a Beckman CEQ8000 capillary
sequencer. Cycling conditions using touchdown PCR were 95°C for 2 min, 30 s
of denaturing, 30 s of annealing (starting at 5°C above the calculated annealing
temperature and dropping by 1°C in each cycle), and 2 min of extension at 72°C.
A further 25 cycles was performed at the annealing temperature, followed by a
final 4-min extension at 72°C. PCR products were purified by incubating with
ExoSAP-IT (Amersham, Little Chalfont, United Kingdom) for 45 min, followed
by enzyme inactivation at 80°C for 15 min. A Genomelab SNP primer extension
kit (Beckman Coulter, High Wycombe, United Kingdom) was used for the SNP
assay reactions. Each reaction was carried out using 3.5 l of cleaned-up PCR
product combined with 4 l SNPStart mastermix (Beckman Coulter, High
Wycombe, United Kingdom) and 50 pmol of each SNP assay primer in a 10-l
reaction. Each assay primer in a given multiplex was designed to be of a different
length for accurate genotyping during fragment analysis. The duplexing of PCR
products in a single reaction mixture used 1 l of each assay product.
Genetic marker association analysis. All statistical analyses were conducted in
Genstat. Virus counts were analyzed by REML using a split-plot fixed-effect
model with time postinfection, sex, genotype, and their two- and three-way
interactions. Plots of residuals showed a positive mean variance relationship, and
the virus count was transformed to natural logarithms. Time of death was ana-
lyzed by analysis of variance (ANOVA) with right censoring and by a propor-
tional hazards model; treatment effects were sex, genotype, and their two-way
interaction. Lesion scores were analyzed by chi-square analysis of tables of lesion
scores and genotype ignoring sex to maximize the size of subclasses.
Microarray accession number. Array data have been submitted to Array
Express under accession number E-TABM-721.
RESULTS
Host response to MDV infection. To examine the early host
response to infection with MDV, gene expression differences
between infected and control birds in the susceptible line were
analyzed using an Affymetrix chicken whole-genome microar-
ray at 2, 3, and 4 dpi. Little difference was seen between
infected and control birds at 2 dpi, except for the statistically
significant downregulation of IgG heavy chain (IgG-H) in in-
fected birds in both the thymus and the spleen. Statistically
significant gene expression differences in both spleen and thy-
mus of infected versus control birds were seen at both 3 and 4
dpi, with more genes differentially expressed (DE) at the later
time point (1,245 DE genes in spleen and 1,234 DE genes in
thymus) (see Table S3 in the supplemental material).
Genes of known immune function upregulated during the
host response to infection with MDV (i.e., expression levels
upregulated in infected compared to control birds) included
some which had been identified in previous studies. These
included both type I (IFNA) and type II (IFNG) interferons
(IFN), some interleukins and interleukin receptors (IL-6,
IL13R2A, and IL-18), the proinflammatory chemokine CCLi7
(previously called ah221), genes involved in the interferon re-
sponse (such as the signaling molecule interferon regulatory
factor 1 [IRF1]), inducible nitric oxide synthase (NOS2A), the
lymphocyte antigen Ly-6E precursor (SCA2), the quiescence-
specific protein P20K, and the proinflammatory protease gran-
zyme A (GZMA) (29, 30, 31, 41).
In addition, several other innate immune function genes
were upregulated, including the Toll-like receptors TLR3 and
TLR15, the chemokines CCLi2, CCLi3, CCLi6, CCL17, and
CCL19, more genes involved in controlling the interferon re-
sponse (BATF3, IFIH1, IFIT-like ISG12, MX1, STAT1, SOCS1,
and SOCS3), the lysozyme gene (LYG2), and the avidin gene
(AVD).
In contrast, a subset of genes was downregulated at 3 and
4 dpi with MDV, i.e., expression levels were downregulated
in infected birds. In this category, genes included IgG-H (as
at 2 dpi), some avian beta-defensins (AvBD1, AvBD2, and
AvBD4), the matrix metalloprotein genes MMP2, MMP7,
and MMP13, several lectins and collectin genes (CLEC3B,
COLEC10, and COLEC12), the chemokine receptor CCR6,
the adhesion molecule AMIGO2, and the dendritic cell
(DC) surface molecule gene Tim4 (a costimulatory molecule
for Th2 T cells). Interestingly, the most highly downregu-
lated genes have no known function in innate immune re-
sponses, including type XII collagen (COL12A1) and
SLC40A1.
Functional analysis of differentially expressed gene sets. To
determine which biological pathways are altered during the
host response to infection with MDV, the microarray data
were analyzed using Pathway Express (15). Based upon the
KEGG pathways (23), this program displays, pictorially,
genes with altered expression patterns (compared to a rel-
evant control) in any given biological pathway. Factors con-
sidered by Pathway Express include the magnitude of a
gene’s expression change and its position and interactions
within any given pathway, thus including an impact factor
when calculating statistically significant pathways. These
pathway diagrams are useful in establishing which gene net-
works are involved in a particular experimental response.
Table 1 shows the pathways which are significantly (FDR-
corrected P value of 0.25) affected during the host re-
sponse to MDV infection. Pathways seen to be involved
include cytokine-receptor interaction and the Toll-like re-
ceptor and JAK-STAT signaling pathways, which play inte-
gral roles during the innate immune response. Figure S1 in
the supplemental material shows pictorial examples of the
pathways perturbed during the early response to MDV in-
fection. Genes involved in apoptosis were upregulated,
while genes involved in tight junction formation and main-
tenance were downregulated. MDV requires cell-to-cell
contact for dispersal throughout the body, so the downregu-
lation of genes involved in tight junctions presumably re-
flects a mechanism by which the virus promotes such con-
tact. (These diagrams are based on the human pathways and
so in some cases are not completely demonstrative of the
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chicken pathways, i.e., avian-specific genes are not repre-
sented.)
Utilizing the CLICK algorithm within the Expander pro-
gram (44) allowed us to cluster genes into groups with similar
expression profiles, thus identifying genes likely to be involved
in the host response to MDV. Figure 1 shows the expression
profile of genes either upregulated or downregulated in re-
sponse to MDV infection compared to levels in age-matched
uninfected controls (see Table S3 in the supplemental material
for genes involved in this response). It was apparent that sim-
ilar profiles were present, i.e., some genes were inherently
more highly expressed in the resistant line, and some were
inherently more highly expressed in the susceptible line (see
Table S4 in the supplemental material for genes showing this
response).
To gain insight into the function of the genes activated
during the host response, the Expander program was also used
to analyze the gene ontology (GO) functional annotations of
the differentially expressed genes. Figure 2A shows the biolog-
ical process terms which were significantly enriched in the
genes differentially expressed during the host response to in-
fection. As might be expected, these include immune response,
cytokine activity, and regulation of apoptosis. How these genes
are transcriptionally regulated also can be determined using
Expander software. Potential or known transcription factor
binding sites present in the differentially expressed genes which
are significantly overrepresented can be identified. Figure 2B
shows that genes upregulated during the host response had a
higher proportion of ISRE (interferon-stimulated response el-
ement) sites than would be represented by chance in a random
sample of genes. The frequency ratio (actual frequency of sites
in a gene set divided by the frequency of the background) is
1.71, i.e., nearly twice as many ISRE sites than would be ex-
pected by chance (P  0.0001).
HIC1 (hypermethylated in cancer 1) binding sites were sig-
nificantly (P 0.0001) enriched (frequency ratio of 1.24) in the
promoters of genes which were repressed during the host re-
sponse. HIC1 acts as a tumor suppressor (17, 49).
Complementing the findings from Pathway Express, ingenu-
ity pathway analysis (IPA) allowed us to identify which biolog-
ical networks and pathways are most highly involved during the
host response to MDV infection. The most significant path-
ways are represented in Fig. 3. It can be clearly seen that
processes involved in innate immunity and signaling constitute
the majority of pathways highlighted. Receptor recognition of
PAMPs, the interferon response, apoptosis signaling, and the
involvement of various immune cell types (DC, natural killer
TABLE 1. Pathway Express analysis of the host response to MDV infection in the spleen
Rank Pathway name Impact factor No. of input genes/no.of pathway genes Corrected P value
1 Leukocyte transendothelial migration 69.707 10/119 3.77E29
2 Cell adhesion molecules 46.582 15/134 2.80E19
3 Adherens junction 24.326 3/78 6.90E10
4 Cytokine-cytokine receptor interaction 12.714 22/263 4.13E05
5 Antigen processing and presentation 10.45 8/89 3.31E04
6 Complement and coagulation cascades 10.161 10/69 4.31E04
7 Systemic lupus erythematosus 8.129 8/144 0.002691804
8 Jak-STAT signaling pathway 8.075 15/155 0.002824351
9 Toll-like receptor signaling pathway 6.922 11/102 0.007809953
10 Graft-vs-host disease 6.241 3/42 0.014104792
11 Type II diabetes mellitus 5.744 4/45 0.021593849
12 Long-term depression 5.653 8/75 0.023331938
13 Extracellular matrix-receptor interaction 5.197 10/84 0.034288862
14 Epithelial cell signaling in Helicobacter pylori infection 4.898 9/68 0.044007875
15 Axon guidance 4.631 13/129 0.054874147
16 Apoptosis 4.538 8/89 0.059227662
17 Natural killer cell-mediated cytotoxicity 4.525 6/135 0.059861797
18 p53 signaling pathway 4.279 7/69 0.073148525
19 Transcription growth factor  signaling pathway 4.171 4/87 0.079823773
20 Allograft rejection 4.1 2/38 0.084520645
21 Tight junction 3.98 9/135 0.093054484
22 ABC transporters 3.825 5/44 0.105273951
23 Type I diabetes mellitus 3.79 2/44 0.108232933
24 Gap junction 3.507 7/96 0.135150237
25 Long-term potentiation 3.495 3/73 0.136417624
26 PPAR signaling pathway 3.486 7/70 0.137375316
27 Basal cell carcinoma 3.456 1/55 0.140612346
28 Pancreatic cancer 3.306 3/72 0.157868858
29 Neuroactive ligand-receptor interaction 3.174 11/256 0.174623126
30 Proteasome 2.969 1/48 0.203826563
31 Amyotrophic lateral sclerosis 2.891 4/56 0.216030904
32 Vibrio cholerae infection 2.775 6/62 0.235369275
33 Pathogenic Escherichia coli infection 2.737 4/54 0.242024371
VOL. 85, 2011 HOST AND PATHOGEN RESPONSES TO MDV INFECTION 11149
 o
n
 Septem
ber 10, 2017 by UQ Library
http://jvi.asm.org/
D
ow
nloaded from
 
cells, etc.) all can be seen to play an important role in MDV
infection.
Inherent differences between susceptible and resistant lines.
Resistance to MD inherent between the lines could be due to
a number of mechanisms. For example, line 61 could simply
express certain genes, such as those involved in key innate
immune responses, at a constitutively higher level than that of
line 72 and thus mount a stronger innate response upon infec-
tion, limiting viral replication and disease. Alternatively, fol-
lowing infection, line 61 could upregulate the expression of key
immune function genes to a greater degree than line 72, thus
mounting a stronger induced immune response. Either or both
mechanisms could contribute to MD resistance.
Gene expression differences were identified between the two
lines (395 DE genes in spleen and 177 DE genes in thymus)
(see Table S4 in the supplemental material) in tissues from the
control, uninfected birds, including the following genes, which
were more highly expressed in line 61 than line 72, that are
known to be involved in the innate immune response:
DNAJC3, DDT, NMU, GSTO1, VIP, HPS5, MMP7, FGFR3,
HSCB, E2F4, SFTPA2, and GNG12. There are therefore genes
whose constitutive expression is different between susceptible
and resistant birds, even before infection occurs.
Following infection, differences in gene expression levels
also were seen between the two lines (539 DE genes in
spleen and 156 DE genes in thymus) (see Table S5 in the
supplemental material). Immune genes more highly ex-
pressed in the resistant line included IgG-H, AMIGO2,
MMP13, and CLEC3B, while genes more highly expressed in
the susceptible line included AVD, IRG1, HSP25, ART1,
IL-18, NOS2A, CXCL13, CCLi2, MX1, SOCS1, and IL-6.
There are therefore also immune genes whose expression is
differentially upregulated following infection.
MDV QTL candidate genes. Many different regions of the
chicken genome have been identified as being QTL involved in
MDV infection (see Table S1 in the supplemental material),
although very few actual genes have been shown to have a
causative role in the disease. Genes underlying the known QTL
(based on Ensembl data, release 62) were compared to the lists
of differentially expressed genes from these experiments, and
there was a degree of overlap (see Tables S3 and S5 in the
supplemental material). Between 26 and 30% of the differen-
FIG. 1. Gene expression clusters generated using the Expander program (http://acgt.cs.tau.ac.il/expander/expander.html). Shown are the
expression profiles of genes upregulated during the response to virus (A) and those downregulated (B). When genes expressed in the two different
lines were examined, similar profiles were noted: gene expression was inherently higher in the resistant line (C), and genes were more highly
expressed in the susceptible line (D).
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tially expressed genes are located under a previously reported
QTL for MD resistance and therefore are potential candidate
genes for controlling the resistance phenotype.
Confirmatory real-time quantitative RT-PCR. The differen-
tial expression of 17 genes (Table 2), chosen as potential can-
didates for involvement in disease resistance, was verified by
qRT-PCR (see Fig. S2 in the supplemental material). These
genes showed differential expression between the susceptible
and resistant lines of birds (either inherently or following in-
fection), and 10 of the genes chosen also lie within a known
MD QTL region (Table 2).
Genetic association of genetic variants in candidate genes
with MD. The 5 flanking region (assumed to contain the
proximal promoter) of 16 of the candidate genes (IL-6 primers
FIG. 2. Overrepresentation analysis using the Expander program. (A) The GO biological processes which are significantly enriched during the
host response to infection. The frequency of genes of a functional class within the examined set is described as a percentage of the total.
(B) Transcription factor binding sites present in differentially expressed genes which are significantly overrepresented in up- and downregulated
genes during the host response to MDV infection. The frequency ratio (frequency of the set divided by the frequency of the background) is shown.
FIG. 3. Ingenuity pathway analysis of the host response to MDV infection. Shown are the most highly represented canonical pathways as
revealed after IPA of genes differentially expressed during the host response to MDV (in the spleen). The line represents the ratio of the number
of genes represented within each pathway to the total number of genes in the pathway.
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failed to generate sequence in line 72) were sequenced from
DNA from several individuals from lines 61 and 72 to identify
SNPs between the two lines. Nine of these genes exhibited
polymorphisms between the lines. Six of these contained SNPs
which result in changes to known transcription factor binding
sites, as determined using the TRANSFAC database (32) (Ta-
ble 3; also see Fig. S3 and S4 in the supplemental material).
SNPs from five of these genes (MMP13, SFTPA2, IRG1,
AMIGO2, and DDT) were genotyped in a backcross experi-
ment, specifically in progeny of a (61 72)72 backcross, to
assess allele segregation (the SNPs found within the MMP9
promoter region were not fixed in the lines). The backcross
progeny had been challenged with MDV and scored postin-
fection for several different phenotypes: viral load at 4, 11, and
39 dpi, tumor formation, and survival. Forty-seven animals
were used for the mapping analysis, being the extremes of the
experimental population as either survivors or those that died
with the highest viral titers.
The means, standard errors, and medians from the raw data for
virus counts (per spleen) by SNP genotype for each gene for the
top/tail data set are given in Table 4. There were no statistically
significant differences between the two genotypes for AMIGO2,
DDT, MMP13, or SFTPA2. There was a significant (P  0.05)
effect for IRG1 genotypes, and these were further investigated
after genotyping the remaining 38 middle-ranking birds of the
backcross. The raw data from the full data set are summarized by
IRG1 genotype in Table 4. Interaction effects were not significant,
and the final model included main effects for time postinfection
(p.i.), sex, and IRG1 genotype. There was a significant effect of
time p.i. (P  0.001) and SNP genotype for IRG1 (P  0.033),
whereas differences between the sexes were not significant. The
marginal means for each time point postinfection were 9.23,
10.79, and 10.82 (sed 0.125), respectively, for 4, 11, and 39 dpi
(back-transformed medians from viral DNA counts were 10,199,
48,533, and 50,011); means for IRG1 SNP AG and GG were
10.41 and 10.15 (sed 0.126) (back-transformed medians from viral
DNA counts were 33,190 and 25,591); means for female and male
chicks were 10.29 and 10.27 (sed 0.126) (back-transformed medi-
ans from viral DNA counts were 29,437 and 28,854). Both anal-
yses by censored ANOVA (survivors were killed 150 dpi) and
proportional hazard models of survival time p.i. showed no sta-
tistical differences between sexes or genotypes. The mean (	
standard errors of the means)-adjusted times to death p.i. for SNP
genotypes AG and GG were 81 	 6.9 and 84 	 6.9 days, respec-
tively. The pattern of death p.i. was similar for both genotypes
(proportional hazard results not shown). There were no statistical
TABLE 2. Candidate genes for Marek’s disease resistance
Gene Description Analysisa Foldchange Tissue
b Comment
Accession no.
GenBank Ensembl
IgG-H IgG H-chain (HC36) D-J-C D 10–22 S and T X07174
AMIGO2 Adhesion molecule with Ig-like
domain 2
D 5 S XM_416052 ENSGALG00000009739
MMP13 Matrix metalloproteinase-13 D 3 S XM_001235209 ENSGALG00000017183
CLEC3B Tetranectin D 3 S NM_204666 ENSGALG00000011883
AVD Avidin precursor D 38 S Between 2 QTL NM_205320 ENSGALG00000023622
IFNA Alpha interferon D 28 T Between 2 QTL NM_205427 ENSGALG00000013245
MMP9 Matrix metalloproteinase-9 D 10 T NM_204667 ENSGALG00000006992
IL-18 Interleukin-18 precursor D 5 S NM_204608 ENSGALG00000007874
TLR15 Toll-like receptor 15 D 3 S NM_001037835 ENSGALG00000008166
MX1 Interferon-induced GTP-binding
protein Mx.
D 3–4 S Under QTL (MD2) NM_204609 ENSGALG00000016142
IL-6 Mature chil-6 D 2–4 S Near MD3 NM_204628 ENSGALG00000010915
FN1 Fibronectin D 3 S Under QTL (MD10) XM_421868 ENSGALG00000003578
IRG1 Immunoresponsive protein 1 D 14 S Quite near MD2 NM_001030821 ENSGALG00000016919
DDT d-Dopachrome tautomerase I 79–110 S and T Under QTL (MD24) NM_001030667 ENSGALG00000006350
DNAJC3 DnaJ homolog subfamily C
member 3
I 14–27 S and T Under QTL (MD2) NM_001008437 ENSGALG00000016894
SFTPA2 Lung lectin precursor I 17 S Under QTL (MD22) NM_001039166 ENSGALG00000002496
GNG12 Guanine nucleotide-binding
protein
I 9 S Under QTL (MD23) XM_001234702 ENSGALG00000020596
a D, differential response between the lines upon infection; I, inherently different between control birds of the resistant and susceptible lines.
b S, spleen; T, thymus.
TABLE 3. SNPs found in transcription factor binding sites in the promoter regions of six candidate genes
MDV strain No. of SNPsbetween lines
No. of SNPs in TF
binding sites Comment(s)
MMP13 12 3 Line 6 has an HMF1 site; line 7 has GATA4 and Hand1:E47 sites
SFTPA2 8 3 Line 6 has MRF2 and FAC1 sites; line 7 has IPF1 and TBP sites
IRG1 7 2 Line 7 has extra Arnt and PPAR
:RXR sites
AMIGO2 5 2 Line 6 has extra BRCA1:USF2 and MEIS1B:HOXA9 sites
DDT 4 2 Kid3 site created (line 7); TCF11 site instead of PAX5, which is in line 6
MMP9 4 2 Line 6 has extra NF-1 and PPARalpha sites; line 7 has an extra Pax5 site
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differences in lesion scores between genotypes. However, com-
paring the types of lesions found suggests that the homozygote
genotype preferentially targets the neural system, and the hetero-
zygote targets the viscera (P  0.029). This helps explain the
lower viral loads seen in homozygous birds, because the IRG1
homozygote alleles confer resistance to virus uptake and thus
provide protection from visceral lymphoma formation.
The fact that a backcross was utilized assumes that the suscep-
tible allele is codominant, because if it was dominant no differ-
ence between the two genotypes would be seen. The lack of effect
of the other candidate genes therefore may not mean that they
are not involved in resistance.
Potential role of IRG1 in MD susceptibility. Immunorespon-
sive gene 1 (IRG1) is an orthologue of the bacterial methylcitrate
dehydratase gene (9) and is induced by lipopolysaccharide (LPS)
(28). Our expression data show that this gene is more highly
expressed in the susceptible line following infection with MDV,
indicating a candidate susceptibility locus. When the promoter
regions of this gene were sequenced in lines 61 and 72 and ana-
lyzed by TRANSFAC, seven SNPs were identified, two of which
resulted in changes to known transcription factor binding sites.
Compared to line 61 (MD resistant), line 72 (MD susceptible) has
extra ARNT (aryl hydrocarbon receptor nuclear translocator)
and PPAR
 (peroxisome proliferator-activated receptor gamma)
binding sites (see Fig. S4 in the supplemental material). The SNP
which was analyzed and found to segregate with susceptibility to
MD is that which creates an ARNT binding site in line 72. ARNT
is required for the activity of the dioxin receptor and for the
ligand-binding subunit to translocate from the cytosol to the nu-
cleus after ligand binding. The complex then initiates the tran-
scription of genes involved in the activation of polycyclic aromatic
hydrocarbon (PAH) procarcinogens. The role, if any, of PAH
procarcinogens in MD pathology has never been evaluated, al-
though it is interesting that increased IRG1 expression, in a line
of chickens susceptible to infection with a tumor-causing herpes-
virus, correlates with an SNP that creates a binding site in the
IRG1 promoter for a transcription factor involved in the induc-
tion of carcinogens in another system.
The analysis of the host response to MDV in spleen at 4 dpi
using IPA enables us to see the biological interaction network
involving IRG1. Figure 4A shows how IRG1 is involved in the
inflammatory response via the actions of MyD88 (myeloid differ-
entiation primary response gene 88) and STAT1 (signal trans-
ducer and activator of transcription 1). IPA also allows us to
examine all of the previously identified interactions in which
IRG1 is thought to be involved (Fig. 4B). Toll-like receptor 9,
tumor necrosis factor, gamma interferon, interleukin-1B, and
bacterial lipopolysaccharide are just some of the molecules which
are known to be involved with the currently unidentified role of
IRG1.
To investigate the possible function of IRG1, we analyzed
the expression profile of this gene during the host response
to MDV infection and compared it to other genes with
similar profiles. Using Biolayout Express 3D (47), we iden-
tified all genes (179) from this analysis having similar ex-
pression profiles and that cluster with IRG1. This cluster of
genes was then analyzed using programs such as EasyGO
and IPA. Many of the genes which cluster together with
IRG1 are shown to be involved in apoptosis or the regula-
tion of apoptosis (Fig. 5A and B). Based on these findings
and the mitochondrial localization of IRG1 in mice, we
hypothesize that the product of this gene also plays a part in
the apoptosis pathway.
To understand how IRG1 is regulated, we used the Ex-
pander program to cluster the genes with similar expression
profiles (generated using Biolayout Express 3D software). This
generated four subclusters. These subclusters were examined
for the enrichment of transcription factor binding sites, and
one was found to be highly overrepresented (more than four
times the level expected by chance) by genes containing bind-
ing sites for the transcription factor OCT1 (also called
POU2F1) (Fig. 5C). OCT1 binds to the octamer motif (5-AT
TABLE 4. Raw data for virus countsa
Gene SNP
Virus count (means 	 SEM) at dpi:
4 11 39
AMIGO2 TC 15,336 	 3,126 (9,775) 55,763 	 5,710 (57,075) 65,321 	 6,109 (73,387)
CC 13,002 	 2,104 (12,215) 54,677 	 3,908 (53,420) 53,739 	 6,542 (52,344)
DDT CT 10,452 	 1,327 (10,062) 56,160 	 4,782 (53,132) 62,411 	 5,938 (70,093)
TT 19,537 	 3,877 (14,048) 53,864 	 4,952 (55,989) 55,208 	 7,046 (59,029)
MMP13 CG 16,467 	 3,386 (12,072) 58,376 	 5,280 (59,370) 66,909 	 6,334 (71,740)
GG 11,871 	 1,537 (12,014) 52,218 	 4,502 (51,932) 52,862 	 6,213 (56,159)
SFTPA2 TC 14,158 	 2,832 (11,734) 57,632 	 5,681 (51,714) 54,323 	 6,242 (57,716)
CC 14,176 	 2,532 (12,206) 53,454 	 4,348 (55,989) 63,048 	 6,347 (64,016)
IRG1 AG 17,154 	 2,793 (12,748) 62,757 	 4,091 (61,230) 65,134 	 5,771 (66,335)
GG 9,857 	 1,794 (6,497) 45,072 	 5,230 (45,072) 51,413 	 6,986 (55,215)
IRG1 all AG 16,415 	 2,546 (12,349) 59,843 	 3,303 (55,989) 66,813 	 4,449 (67,500)
GG 12,948 	 2,064 (7,974) 47,563 	 3,276 (50,954) 61,017 	 5,223 (63,878)
a Raw data, with median values in parentheses, are for backcrossed chickens classified by different SNP genotypes for five genes in the top-and-tail-selected data set
and for the complete set of data for IRG1 (IRG1 all).
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TTGCAT-3) and activates the promoters of the genes, such as
some small nuclear RNAs (snRNA), histone H2B, and immu-
noglobulins. OCT1 modulates transcription transactivation by
NR3C1, AR, and PGR. It is interesting that during another
herpesvirus infection, human herpes simplex virus (HSV),
OCT1 forms a multiprotein-DNA complex with the viral trans-
activator protein VP16 and HCFC1, thereby enabling the tran-
scription of the viral immediate-early genes.
FIG. 4. Network analysis using the IPA program. (A) Interaction network representing genes involved in the inflammatory response, showing
genes upregulated in response to MDV infection (red) and genes downregulated (green). IRG1 is seen to be highly upregulated in this analysis.
(B) Genes currently known to interact with IRG1.
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DISCUSSION
The early host response to MDV infection. To further char-
acterize the chicken innate immune response to infection with
MDV, spleen and thymus samples from 2, 3, and 4 dpi were
analyzed. Infected and control birds of the susceptible line
were compared, with the hypothesis being that these birds had
the most viral replication, which therefore was most likely to
trigger stronger, but not necessarily more effective, immune
responses. Responses in the spleen and thymus, as measured at
the transcriptional level using the whole-genome microarrays,
FIG. 5. Analysis of the IRG1-containing cluster of genes identified using Biolayout Express 3D software. (A) EasyGO analysis shows a
significant enrichment of genes involved in apoptosis and the regulation of apoptosis. (B) IPA analysis also reveals cell death to be a highly featured
function of the genes in this cluster. (C) A subcluster identified using the Expander program is seen to be highly overrepresented (more than 4-fold)
by genes which contain a binding site for the transcription factor OCT1 (octamer-binding transcription factor 1). Genes with binding sites for DBP
(albumin D box-binding protein) also are seen to be enriched. DBP is thought to be involved in the modulation of circadian rhythms.
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were detectable only at significant levels after 2 dpi (when the
only difference in expression level between infected and con-
trol birds was for IgG-H, which was decreased following infec-
tion). MDV is normally detectable in most secondary lymphoid
organs, including the spleen, from 2 to 7 dpi, peaking at 4 dpi
(3). The lack of response at 2 dpi in this experiment possibly
reflects the low level of virus in the spleen at this time point. By
3 dpi, an induced innate response has been established (22),
and many proinflammatory cytokines and chemokines were
activated. The expression of genes involved in apoptosis, im-
mune-related signaling pathways (e.g., the TLR and Jak-Stat
pathways), transcription factors, and receptors was upregu-
lated. Genes involved in tissue remodelling were downregu-
lated, including some involved in leukocyte transendothelial
migration, and in the formation and maintenance of both ad-
herens and tight junctions. As expected, there was a higher
transcriptional response in the spleen than in the thymus, the
former being the primary target organ for MDV.
The expression of certain TLRs also was increased during
the host response, specifically TLR3, TLR15, TLR1B, and
TLR4 in the spleen, and the same four TLRs plus TLR21 in the
thymus. The modulation of TLR expression following the rec-
ognition of a pathogen-associated molecular pattern (PAMP)
is poorly understood in the chicken. It is interesting that MDV,
presumably recognized through its CpG motifs in its double-
stranded DNA genome by TLR21 (which recognizes CpG in
the chicken [5, 25], rather than TLR9, which is absent), up-
regulates the expression of TLRs that recognize double-
stranded RNA (TLR3) and bacterial cell surface components
(TLR1B and TLR4). TLR15 is an avian-specific receptor and
is of unknown function, although it is upregulated in response
to Salmonella infection (20) and has been predicted to recog-
nize a pathogen-surface PAMP (37).
In mammals, the chemokine receptor CCR6 is normally
found on immature DCs, Th17 cells, and unactivated memory
T cells. It is also downregulated on activated T cells, which
would fit with its downregulation in the spleen and thymus at
4 dpi with MDV, as at this stage of infection T cells are
becoming activated and in turn infected with MDV. It also
could be explained in part by the maturation of DCs in re-
sponse to the MDV infection, as mature DCs in both mammals
(39) and chickens (51) downregulate CCR6. The expression of
the DC-expressed costimulatory molecule for Th2 cells, Tim4,
also was downregulated, suggesting, as one would expect, the
maturation of DCs to drive an antiviral Th1 response. This is
in contrast to recent reports suggesting that MDV infection
biases the immune response toward a Th2 (18) or Treg (6)
response, either of which would be advantageous to the virus.
The analysis of potential or known transcription factor bind-
ing sites in the differentially expressed genes that were statis-
tically significantly overrepresented yielded both expected and
unexpected results. Genes whose expression was upregulated
during the host response had a high proportion of ISRE sites
in their promoters. This was to be expected, as MDV infection
induces type I IFNs (18, 22), and downstream signaling events
from the IFN- receptor, used by all type I IFNs, lead to the
induction of the expression of IFN-stimulated genes which
contain ISRE sites.
The overrepresentation of genes with HIC1 binding sites in
their promoters among those genes whose expression was re-
pressed during the host response was unexpected and suggests
a new pathological mechanism for MDV. HIC1 acts as a tumor
suppressor in mammals acting at the intersection of regulatory
loops involving p53-dependent and E2F-1-dependent cell sur-
vival, growth control, and stress responses (17, 49). HIC1 tran-
scriptional repressor function occurs by the recruitment of
CtBP1 through the conserved PXDLSXK/R motif, and we
have shown previously that the interaction of the principal
MDV oncogene meq with CtBP is crucial for MD oncogenicity
(4). The meq oncogene is expressed later in infection, peaking
at 3 weeks p.i., but as early as 4 dpi MDV infection causes the
downregulation of genes whose expression would be upregu-
lated by the tumor suppressor HIC1. In other words, MDV
infection is blocking an antitumor mechanism long before the
MDV oncogene is expressed. The precise mechanism by which
MDV infection could be driving the suppression of this anti-
tumor response remains to be determined.
MD resistance genes. The analysis of samples from MD-
susceptible and -resistant birds, with and without infection with
MDV, using whole-genome microarrays has identified genes
which either show different inherent levels of gene expression
(without infection) between the lines or are transcribed differ-
ently following infection, thus potentially eliciting differing
host responses. By analyzing the list of genes differentially
expressed between the susceptible and resistant lines (either
inherently or following infection), 16 genes were identified as
potential candidates for involvement in disease resistance. We
sequenced the promoters of these genes from multiple indi-
viduals from both lines, seven of which contained promoter
SNPs resulting in changes to transcription factor binding sites.
The allelic segregation of six of these was tested in a backcross
MDV experiment, and one, IRG1 (immunoresponsive gene 1),
which is more highly expressed in the susceptible line, showed
a significant effect.
Interestingly, higher viral load was associated with the het-
erozygote genotype at the IRG1 locus (61/72). This is in con-
trast to what one might have expected, given that 72/72 birds
should be more susceptible to MDV infection. However, we
must bear in mind that this is the analysis of one locus within
a polygenic system. Resistance to MD is not a simple Mende-
lian trait but is highly complex and involves at least 14 separate
quantitative trait loci (33, 52). In addition, epistatic interac-
tions between different QTL influence MDV viremia (10).
Such genetic interactions may also modify the effect of the
IRG1 alleles found in this study. The exact nature of the
polymorphism within the IRG1 promoter (whether it confers
susceptibility to MD infection or whether it is a resistance locus
that we have highlighted within a susceptible background) and
the function of the IRG1 protein itself will obviously require
further functional investigation.
Potential function of IRG1. There is little literature on the
potential role of IRG1 in the immune response in biomedical
model species. It is 1 of at least 35 genes that constitute the
IFN-
/tumor necrosis factor alpha (TNF-)-triggered effector
program in innate immunity in mice (13), with its expression
being highly upregulated by several proinflammatory cytokines
and TLR agonists. Moreover, in the same study it was shown to
localize subcellularly with mitochondria.
The analysis of other genes with an expression profile similar
to that of IRG1 indicates that IRG1 has a role in the apoptosis
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pathway. Apoptosis is often induced in virally infected cells
and is the likely cause of MDV-induced cell death (42). Her-
pesviruses can both trigger and block apoptosis, the former
during productive infections (as would be the case in this
study) and the latter during latency or transformation (14).
The apoptosis of CD4 CD8 T cells in the thymus during
lytic infection with MDV has been reported (34), as has that of
CD4 T cells in peripheral blood at 14 to 21 dpi (35). How-
ever, it is not clear in either case that the apoptotic cells were
infected with MDV. Schat (42) hypothesized that the pro-
longed cytolytic infection associated with very virulent plus
strains of MDV result from those strains having been selected
for decreased antiapoptotic or increased apoptotic ability dur-
ing virus replication in vaccinated chickens. In other words,
increased apoptosis would lead to prolonged and/or increased
viral replication and hence increased pathogenesis. If IRG1
has a role in apoptosis, one would hypothesize that it is pro-
apoptotic, as its expression is increased in the susceptible line
compared to that of the resistant line. Further functional stud-
ies obviously need to be carried out to determine the true role
of this protein in susceptibility to Marek’s disease.
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